Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma

Fig. 4

The anti-glioma ability of Car-B7H3-γδT cells was stronger than that of parental Vγ9Vδ2 T cells in vivo A NSG mouse GBM models were treated with Vγ9Vδ2 T cells, Car-B7H3-γδT cells, or PBS (n = 5). Bioluminescence images of the mouse brain were taken on day 7, 13, and 23 after injection. B Bioluminescence intensity was measured to examine tumor growth. Data are expressed as mean ± SD. ****P < 0.0001. C Kaplan-Meier survival analysis was performed

Back to article page